Reply To: CHG study at COG

  • Chris Donaghey

    Member
    September 20, 2019 at 3:54 pm

    Heard some about it through our MDs.

    It’s still in manuscript phase. But here’s some brief info (second-hand):

    177/400 patients
    CHG vs control (“prepackaged cloth impregnated w mild soap”)

    CLABSI rate w CHG – 5.4
    CLABSI rate w control – 3.1
    IRR – 1.76

    Didn’t say whether MBI-CLABSIs were excluded

    MDRO
    CHG – 15%
    Control – 12%

    Cutaneous adverse events
    CHG – 22 events
    Control -14 events

    My questions/comments that I need answered are many but some offhand I gave were:

    Timeframe
    What is the control soap?
    Those rates aren’t good if MBIs excluded (and aspire to better even with MBIs included)
    That’s a fair amount of cutaneous adverse events for a mild soap
    Type of patients

    ——————————
    Chris Donaghey, MSN, RN, PCNS-BC, CPN, CPHON
    Clinical Nurse Specialist – Riley Cancer Center
    Riley Hospital for Children at IU Health
    Indianapolis, IN 46219
    ——————————
    ——————————————-
    Original Message:
    Sent: 09-20-2019 03:11 PM
    From: Brennah Holley
    Subject: CHG study at COG

    Hi Everyone.
    A presentation was delivered at COG a couple weeks ago re. the efficacy of CHG bathing vs. soap & water. The results were against CHG.
    Are your institutions making any changes in your bathing policy based on this? If so, how are you approaching the issue of noncompliance with SPS?
    Looking forward to your replies!
    Brennah

    ——————————
    Brennah Holley BScN, CPHON
    Clinical Nurse Educator
    CHEO
    Ottawa, ON
    Canada
    ——————————